Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dr.Reddy's Laboratories Ltd (NYSE:RDY)

53.34
Delayed Data
As of Jul 22
 +0.01 / +0.02%
Today’s Change
40.67
Today|||52-Week Range
68.00
+15.23%
Year-to-Date
Teva (TEVA) Provides 2016-2019 Outlook, Shares Gain
Jul 14 / Zacks.com - Paid Partner Content
Looking For Generic Drug Stocks? Pick Up These Winners
Jul 13 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close53.33
Today’s open53.41
Day’s range53.15 - 53.62
Volume177,675
Average volume (3 months)329,915
Market cap$9.1B
Dividend yield0.59%
Data as of 4:02pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-15.85%
Earnings growth (this year)--
Earnings growth (next 5 years)+8.58%
Revenue growth (last year)-2.51%
P/E ratio0.5
Price/Sales3.28
Price/Book4.70

Competitors

 Today’s
change
Today’s
% change
JAZZJazz Pharmaceuticals...-1.58-1.10%
IDXXIDEXX Laboratories I...+0.18+0.19%
MDVNMedivation Inc+0.09+0.14%
VRXValeant Pharmaceutic...-1.66-6.78%
Data as of 4:00pm ET, 07/22/2016

Financials

Last reporting dateJuly 20, 2016
EPS forecast (this quarter)$0.43
Annual revenue (last year)$2.4B
Annual profit (last year)$305.0M
Net profit margin12.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Co-Chairman, Chief Executive Officer &
MD
Gunupati Venkateswara Prasad
President, CFO &
Global Head-IT
Saumen Chakraborty
Corporate headquarters
Hyderabad, Telangana

Forecasts

Partner Offers

Search for Jobs